News about product and service launches
Alliance aims to make SMA testing mandatory in European newborn screening programs by 2025 WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the Company has joined the European Alliance for Newborn Screening in Spinal Muscular Atrophy, also known as the SMA NBS Alliance. Founded by SMA Europe... Read more
SANTA CLARA, Calif., January 25, 2021 Agilent Technologies Inc. (NYSE: A) today announced the release of MassHunter Workstation Plus 11.0, MassHunter Networked Workstation 11.0, and MassHunter BioConfirm. The latest revision of these software enables data integrity consistent with the regulatory requirements from the US FDA and EU EMEA guidance, providing user management, checksums, tamper detection,... Read more
This successful long-running partnership continues to evolve and bring haematology testing innovations to laboratories, globally The new agreement aims to utilise the IT systems to lead to improved clinical decision making and customer experience Blood disorders have a high impact, not only for patients but for society as a whole, accounting for a third of... Read more
January 22, 2021 – JEOL Ltd. (President & COO Izumi Oi) announces the release of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM™ 300 II (JEM-3300), to be released in January 2021. This new cryo-EM has been developed based on the concept of “Quick and easy to operate and get high-contrast and high-resolution... Read more
Hamburg, January 14, 2021 Streamlining the transfer of an upstream bioprocess from research to production scale is critical for reducing biologics development costs and time to market. Eppendorf, a leading life science company, introduces the BioFlo 720, a bioprocess control station for applications at pilot/production scale using single-use bioreactors. With it, Eppendorf now offers one of... Read more
Novel test supports vaccine development studies critical to aiding researchersin understanding immunity levels and disease progression WALTHAM, Mass. – January 14, 2021 – PerkinElmer today announced that its EUROIMMUN business has launched a SARS-CoV-2 Interferon Gamma Release Assay (IGRA) for Research Use Only (RUO) to determine the activity of T-cells reactive to SARS-CoV-2, the pathogen... Read more
Subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations Read more
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common stock and restricted stock... Read more
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common stock and restricted stock... Read more
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common stock and restricted stock... Read more